Test of both static and dynamic balance under varying sensory conditions. Designed to measure balance in higher-functioning active older adults.
10
10-12 minutes
Recommendations for use of the instrument from the Neurology Section of the American Physical Therapy Association’s Multiple Sclerosis Taskforce (MSEDGE), Parkinson’s Taskforce (PD EDGE), Spinal Cord Injury Taskforce (PD EDGE), Stroke Taskforce (StrokEDGE), Traumatic Brain Injury Taskforce (TBI EDGE), and Vestibular Taskforce (Vestibular EDGE) are listed below. These recommendations were developed by a panel of research and clinical experts using a modified Delphi process.
For detailed information about how recommendations were made, please visit: http://www.neuropt.org/go/healthcare-professionals/neurology-section-outcome-measures-recommendations
|
Abbreviations: |
|
|
HR |
Highly Recommend |
|
R |
Recommend |
|
LS / UR |
Reasonable to use, but limited study in target group / Unable to Recommend |
|
NR |
Not Recommended |
Recommendations based on level of care in which the assessment is taken:
|
|
Acute Care |
Inpatient Rehabilitation |
Skilled Nursing Facility |
Outpatient Rehabilitation |
Home Health |
|
MS EDGE |
UR |
UR |
UR |
UR |
UR |
|
TBI EDGE |
LS |
LS |
LS |
LS |
LS |
Recommendations for use based on ambulatory status after brain injury:
|
|
Completely Independent |
Mildly dependant |
Moderately Dependant |
Severely Dependant |
|
TBI EDGE |
LS |
LS |
LS |
NR |
Recommendations based on EDSS Classification:
|
|
EDSS 0.0 – 3.5 |
EDSS 4.0 – 5.5 |
EDSS 6.0 – 7.5 |
EDSS 8.0 – 9.5 |
|
MS EDGE |
UR |
UR |
NR |
NR |
Recommendations for entry-level physical therapy education and use in research:
|
|
Students should learn to administer this tool? (Y/N) |
Students should be exposed to tool? (Y/N) |
Appropriate for use in intervention research studies? (Y/N) |
Is additional research warranted for this tool (Y/N) |
|
MS EDGE |
No |
No |
No |
Yes |
|
TBI EDGE |
No |
No |
No |
Not reported |
The Academy of Oncologic Physical Therapy of the American Physical Therapy Association (APTA) formed the Cancer Evaluation Database to Guide Effectiveness (EDGE) Task Force to provide recommendations for outcome measures to use in patients affected by cancer. Below is the recommendation for use of the Fullerton Advanced Balance Scale. Recommendations were developed by research and clinical experts by critically appraising the literature to assess the psychometric properties and clinical utility of the outcome measure. Outcome measures were ranked using the Cancer EDGE Rating Scale.
Detailed information on recommendations for measures of balance in adult cancer survivors can be found at:
|
|
Cancer EDGE Rating Scale: |
|
|
4 |
Highly recommended |
The outcome measure has excellent psychometric properties (reliability and validity AND have available data to guide interpretation) in condition of interest and excellent clinical utility (≤20 min, equip in clinic, no copyright payments, easy to score); the measure is free or reasonably accessible to a broad range of providers. |
|
3 |
Recommended |
The outcome measure has good psychometric properties (may lack some info about reliability, validity, responsiveness) in the population of interest and good clinical utility (>20 min, some equip, training, copyright fee); OR has excellent psychometric properties but is not free and may require access to specialized testing equipment that is beyond the means of many clinicians or clinics. |
|
2 |
Reasonable to use |
Limited study in the target group; the outcome measure has good or excellent psychometric properties and clinical utility in a related population, but insufficient study in the target population to support higher recommendation. |
|
1 |
Not recommended |
The outcome measure has poor psychometric properties and/or poor clinical utility. |
|
Recommendation for use of the Fullerton Advanced Balance Scale in adult cancer survivors: 4 Highly Recommended |
Fullerton Advanced Balance Scale translations:
German:
http://link.springer.com/article/10.1007%2Fs00391-011-0236-8
These translations, and links to them, are subject to the Terms and Conditions of Use of the Rehab Measures Database. RIC is not responsible for and does not endorse the content, products or services of any third-party website, and does not make any representations regarding its quality, content or accuracy. If you would like to contribute a language translation to the RMD, please contact us at rehabmeasures@ric.org.
Do you see an error or have a suggestion for this instrument summary? Please e-mail us!
Fibromyalgia: (Cherry et al, 2012, n = 68; mean age=59.54(7.50) years)
Predictive validity:
Breast cancer (post chemotherapy): (Wampler et al, 2007; n=40, 20 with breast cancer, 20 healthy controls; mean age for sick = 50.35 (9.34) years; mean age for healthy = 49.60(9.08) years; treated with taxane chemotherapy)
Breast Cancer: (Wampler et al, 2007)
Breast cancer (post chemotherapy): (Wampler et al, 2007)
Older adults (>=65 years): (Hernandez and Rose, 2008; n=192; mean age=77(6.5) years, independently, healthy functioning adults, n= 133 without fall in previous 12 months / n= 59 reported falling 2 or more times previous 12 months)
Older Adults: (Rose et al, 2006; n = 46, mean age = 75(6.2) years; with (n = 31) and without balance problems (n = 15)); subset of n = 31 for test-retest, mean age 75 (6.2) years, community dwelling healthy adults)
Older Adults: (Klein et al, 2010, n = 480 community dwelling adults; mean age = 76.4(7.1) years; 20% reported >= 2 falls in past 12 months)
Older Adults: (Rose et al, 2006; subset of n =31 for test-retest reliability; mean age = 75 (6.2) years)
Older adults: (Rose et al, 2006)
Older adults: (Klein et al, 2010)
Older adults: (Rose and Lucchese, 2006)
Concurrent validity:
Older adults:(Hernandez and Rose, 2008)
Predictive validity:
Older adults: (Rose et al, 2006; subset of n=31, mean age 75 (6.2) years)
Convergent validity:
Older adults: (Rose et al, 2006)
Older adults: (Rose et al, 2006)
Older adults: (Hernandez and Rose, 2008)
Cherry, B. J., Zettel-Watson, L., et al. (2012). "Positive associations between physical and cognitive performance measures in fibromyalgia." Arch Phys Med Rehabil 93(1): 62-71. Find it on PubMed
Hernandez, D. and Rose, D. J. (2008). "Predicting which older adults will or will not fall using the Fullerton Advanced Balance scale." Archives of Physical Medicine & Rehabilitation 89(12): 2309-2315. Find it on PubMed
Klein, P. J., Fiedler, R. C., et al. (2011). "Rasch Analysis of the Fullerton Advanced Balance (FAB) Scale." Physiother Can 63(1): 115-125. Find it on PubMed
Langley, F. A. and Mackintosh, S. F. H. (2007). "Functional balance assessment of older community dwelling adults: a systematic review of the literature." Internet Journal of Allied Health Sciences & Practice 5(4): 11p. Find it on PubMed
Rose, D. J., Lucchese, N., et al. (2006). "Development of a multidimensional balance scale for use with functionally independent older adults." Archives of Physical Medicine and Rehabilitation 87(11): 1478-1485. Find it on PubMed
Wampler, M. A., Topp, K. S., et al. (2007). "Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy." Arch Phys Med Rehabil 88(8): 1002-1008. Find it on PubMed
We have reviewed more than 500 instruments for use with a number of diagnoses including stroke, spinal cord injury and traumatic brain injury among several others.